The International Safety Group – a company in the portfolio of AJ Discala’s OmniView Capital Advisors – has recently expanded its work. It is now operating in the oilfield and hydrofracking site safety business that is focused in the Midwest region of America. ISG is doing this through Safety Oil Services LLC (“SOS”), a newly-established subsidiary.
Alongside this, the company appointed Brian Main as Chief Consultant, in the hope that he will bring “advanced technologies and safety protocols” to an area ISG feels warrants its services and products. Main comes to this position with significant experience having worked in real estate development companies, most notably when he built a workforce housing camp for oil and gas field employees. Having Main at ISG expands the company’s services to high-growth energy, oil and gas sectors.
According to CEO and President of ISG, Michael Gianatasio, “SOS is clearly a solid fit into our business strategy. [It] not only diversifies our geographic reach but also brings us into a high growth industry where we can utilize our strengths in the safety field. We will continue to look for other similar opportunities.”
Blue Calypso Inc. announced gross proceeds of $2.4m, following the completion of its private placement. The company – within the portfolio of AJ Discala’s OmniView Capital Advisors – then issued a 10 percent convertible Debenture in this amount along with 1.2 million shares of common stock to the investor. According to Chairman and CEO of Blue Calypso, Bill Ogle, the company is “pleased that this new investment and [its] recent agreement to settle [its] outstanding senior secured convertible debentures without any dilution to [its] stockholders has dramatically improved [its] financial position. The purchase of these debentures at a premium to market is yet another vote of confidence in Blue Calypso.”
Timothy Lane sits on the advisory board at OmniView Capital Advisors, LLC, working alongside CEO of the company, AJ Discala. He brings substantial expertise to his work at the company, being CEO of PepsiCo Restaurants International for Asia and the Middle East, and directing KFC’s introduction into China, giving it the lead position in today’s market. Indeed, it was Lane who helped develop PepsiCo from 250 loss-making stores, to a store-network of 2,500 generating revenue of $2.5bn and more than $200m in profits within six years. As well, Lane is a co-founder of The Afghanistan Reconstruction Company, LLC whereby he set up Afghanistan’s first privately owned bank in conjunction with Asian Development Bank. Lane was also President and CEO of Holiday Inn Worldwide.
Timothy Lane has most recently been in the news with his appointment as Chairman to the Board of Directors at True Drinks, Inc. (a provider of healthy beverages).
Sitting on the advisory board at AJ Discala’s OmniView Capital Advisors, is William J. Foster IV. He brings to the firm long-standing expertise in the legal area, having practiced law for over four decades. In the early 1970s, Foster began his career in the field as Counsel to the National Association of Securities Dealers Inc. Companies he has been a Partner in over the years include: Rogers, Hoge & Hills; Hertzog, Calamari & Gleason; and McMillan, Constabile, Maker & Perone, LLP. Foster also boasts expertise in the following specific areas: securities regulation of financial institutions, investment companies and broker-dealers. He worked at Greenwich Partners LLC as both General Counsel and Executive VP. Other broader areas Foster practices in include: corporate law; litigation and employment law.
The Health Revenue Assurance Holdings Inc. (HRAA) recently conducted a survey of hospital health information professionals, hospital administrators and compliance employees. The results were that a staggering 20 percent of small- and mid-sized hospitals have not even begun any type of training for the largest shift American healthcare organizations are ever about to encounter – transitioning from ICD-9 to ICD-10.
According to Andrea Clark, CEO of HRAA (a company amongst those in the portfolio of AJ Discala’s OmniView Capital Advisors), “the shift from ICD-9 to ICD-10 is equivalent to learning another language; it will not be as easy as flipping a switch. HIM coders must be exposed and then trained on the fundamentals of ICD-10 to ensure that a hospital’s revenue system remains intact and that millions will not be left on the table when the transition takes place.” Indeed, around 50 percent of the 120+ hospitals surveyed are not following CMS timeliness on transition preparation. As Clark points out, training is “the technical lock for ICD-10 dual coding.” This is currently lacking, the HRAA report found.
One of the top executives working alongside CEO AJ Discala is Jeff Devlin, who holds the position of Chief Marketing Officer at the firm. He came on board to this position in January of this year, bringing to the role more than two-and-a-half decades of expertise in advertising, marketing and new business development. At OmniView he will be directing the firm towards escalated business strategy and further growth.
Of his appointment, CEO AJ Discala said, “we are thrilled that Jeff has agreed to join our Board of Directors as he brings the vital experience that will help grow our company.” Devlin said that he looks forward “to bringing an advertising and marketing perspective to the Board to help leverage the company’s innovative philosophy and maximize business development opportunities.”
Devlin has received an area of honors in his industry include: 21 for outstanding commercials; the Gold Camera from the U.S. International Film Festival as well as permanent display at New York’s Museum of Modern Art of the award-winning piece he made for Visa, Olympics.
Blue Calypso Inc. – a firm in the portfolio managed by AJ Discala’s OmniView Capital Advisors – gained over 31 percent to 35 cents per share. This marks a five-day buying streak for the company. This is good news especially given its fall following the February promotions. It is thought that this new escalation has been given additional momentum by financial data and press releases. Over 750,000 shares were bought up.
The last promotion Blue Calypso encountered was with a budget of $80,000 for 15 emails at the beginning of February. StockEdge.com received $50,000 for the messages. Blue Calypso has definitely gained additional visibility from this news.
Working alongside AJ Discala at OmniView Capital Advisors is Joseph Himy who is the firm’s Chief Financial Officer. He brings to OmniView Capital more than two decades’ of experience spanning a wide variety of industries. This includes: his position as CFO at Vyteris Inc.; Manager of Financial Reporting (LeCroy Corporation); Audit Manager for Baking and Broker Dealer Business Unit (Deloitte & Touche LLP); etc. Throughout these roles Himy has successfully established fiscal models; restructured operational costs and more. He boasts strong leadership skills and expertise in managing and developing staff performance via training programs and setting measurable performance objectives. Himy is also a CPA and on the Board of Directors for two non-profit organizations.
The LBT-886 Asset tracking device has received certification for MIL-STD-461F, “requirements for the Control of Electromagnetic Interference Characteristics of Equipment and Subsystems.” The device, made by LBT (which is amongst the companies in the portfolio of AJ Discala’s OmniView Capital Advisors), was also given certification for MIL-STD-810G, Method 500.5, Procedures 1, 2, 3, and 4. According to LBT CEO Dave Morse, “the ease of the Interface, the unique size, and impressive mobile asset tracking capabilities of the LBT-886 device have attracted a lot of attention for our company and its products. We will continue our efforts to deliver strong applications that meet or exceed both government and military tracking requirements whether on land, sea, or air.”
Health Revenue Assurance Holdings Inc. (HRAA) – a company among those managed by AJ Discala’s OmniView Capital Advisors LLC – recently announced its fiscal statement for end of year December 31, 2002. HRAA provides technology and revenue integrity solutions for healthcare organizations.
The fourth quarter of 2012 was seen by company chair, CEO and founder, Andrea Clark as another success as HRAA “continue[s] to deliver strong results reflected by the record revenues we have achieved. The quarter was also marked with a significant milestone for the Company as we recorded the first sale of our ICD-Visualizerä software solution. This revolutionary product has helped our client to mitigate their risk in preparation for the upcoming mandated switch from ICD-9 to ICD-10 in October of 2014.”
Highlights of the report include: total quarterly revenue increase of 421%; total annual revenue increase of 305% and cash balance increase of $649,958.